AXON
Price
$539.69
Change
-$18.73 (-3.35%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
43.37B
40 days until earnings call
MEIP
Price
$2.13
Change
-$0.02 (-0.93%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
14.33M
Ad is loading...

AXON vs MEIP

Header iconAXON vs MEIP Comparison
Open Charts AXON vs MEIPBanner chart's image
Axon Enterprise
Price$539.69
Change-$18.73 (-3.35%)
Volume$9.45K
Capitalization43.37B
MEI Pharma
Price$2.13
Change-$0.02 (-0.93%)
Volume$142
Capitalization14.33M
AXON vs MEIP Comparison Chart
Loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MEIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXON vs. MEIP commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXON is a StrongBuy and MEIP is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (AXON: $558.42 vs. MEIP: $2.15)
Brand notoriety: AXON and MEIP are both not notable
AXON represents the Aerospace & Defense, while MEIP is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXON: 81% vs. MEIP: 116%
Market capitalization -- AXON: $41.91B vs. MEIP: $14.19M
AXON [@Aerospace & Defense] is valued at $41.91B. MEIP’s [@Biotechnology] market capitalization is $14.19M. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $200.12B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Aerospace & Defense] industry is $17.09B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXON’s FA Score shows that 1 FA rating(s) are green whileMEIP’s FA Score has 0 green FA rating(s).

  • AXON’s FA Score: 1 green, 4 red.
  • MEIP’s FA Score: 0 green, 5 red.
According to our system of comparison, AXON is a better buy in the long-term than MEIP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXON’s TA Score shows that 4 TA indicator(s) are bullish while MEIP’s TA Score has 4 bullish TA indicator(s).

  • AXON’s TA Score: 4 bullish, 2 bearish.
  • MEIP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AXON is a better buy in the short-term than MEIP.

Price Growth

AXON (@Aerospace & Defense) experienced а -0.11% price change this week, while MEIP (@Biotechnology) price change was -7.33% for the same time period.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was -4.25%. For the same industry, the average monthly price growth was -1.98%, and the average quarterly price growth was +13.68%.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

AXON is expected to report earnings on May 13, 2025.

MEIP is expected to report earnings on Aug 31, 2023.

Industries' Descriptions

@Aerospace & Defense (-4.25% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($43.4B) has a higher market cap than MEIP($14.3M). AXON has higher P/E ratio than MEIP: AXON (116.34) vs MEIP (1.09). AXON YTD gains are higher at: -6.041 vs. MEIP (-12.602). AXON has higher annual earnings (EBITDA): 437M vs. MEIP (-29.13M). AXON has more cash in the bank: 986M vs. MEIP (23.7M). MEIP has less debt than AXON: MEIP (11.7M) vs AXON (722M). AXON has higher revenues than MEIP: AXON (2.08B) vs MEIP (0).
AXONMEIPAXON / MEIP
Capitalization43.4B14.3M303,497%
EBITDA437M-29.13M-1,500%
Gain YTD-6.041-12.60248%
P/E Ratio116.341.0910,638%
Revenue2.08B0-
Total Cash986M23.7M4,160%
Total Debt722M11.7M6,171%
FUNDAMENTALS RATINGS
AXON vs MEIP: Fundamental Ratings
AXON
MEIP
OUTLOOK RATING
1..100
8417
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
12100
SMR RATING
1..100
4798
PRICE GROWTH RATING
1..100
4184
P/E GROWTH RATING
1..100
6338
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MEIP's Valuation (62) in the Pharmaceuticals Other industry is in the same range as AXON (92) in the Biotechnology industry. This means that MEIP’s stock grew similarly to AXON’s over the last 12 months.

AXON's Profit vs Risk Rating (12) in the Biotechnology industry is significantly better than the same rating for MEIP (100) in the Pharmaceuticals Other industry. This means that AXON’s stock grew significantly faster than MEIP’s over the last 12 months.

AXON's SMR Rating (47) in the Biotechnology industry is somewhat better than the same rating for MEIP (98) in the Pharmaceuticals Other industry. This means that AXON’s stock grew somewhat faster than MEIP’s over the last 12 months.

AXON's Price Growth Rating (41) in the Biotechnology industry is somewhat better than the same rating for MEIP (84) in the Pharmaceuticals Other industry. This means that AXON’s stock grew somewhat faster than MEIP’s over the last 12 months.

MEIP's P/E Growth Rating (38) in the Pharmaceuticals Other industry is in the same range as AXON (63) in the Biotechnology industry. This means that MEIP’s stock grew similarly to AXON’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AXONMEIP
RSI
ODDS (%)
Bullish Trend 7 days ago
90%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 7 days ago
72%
Declines
ODDS (%)
Bearish Trend 4 days ago
66%
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MEIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASPI5.160.34
+7.05%
ASP Isotopes
GHC1003.5328.29
+2.90%
Graham Holdings Company
IRS13.310.11
+0.83%
IRSA Inversiones Y Representaciones S.A
HOTH0.98N/A
+0.38%
Hoth Therapeutics
TDY499.681.35
+0.27%
Teledyne Technologies

MEIP and

Correlation & Price change

A.I.dvisor indicates that over the last year, MEIP has been loosely correlated with GOSS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MEIP jumps, then GOSS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEIP
1D Price
Change %
MEIP100%
N/A
GOSS - MEIP
45%
Loosely correlated
-1.59%
FBIO - MEIP
28%
Poorly correlated
+4.55%
AXON - MEIP
28%
Poorly correlated
+3.18%
DNLI - MEIP
26%
Poorly correlated
+11.80%
GLUE - MEIP
25%
Poorly correlated
-0.45%
More